Its operating profit hiked 23.7 percent on-year to 194.0 billion won, estimated analyst Baek Un-mok. 

Its three key categories this year will be bio, home meal replacements and processed food for overseas market, noted the analyst, adding that there are a number of favorable factors that will help it gain momentum.
CJ is also undervalued compared to its global peers, according to Baek. 

By Hwang You-mee (glamazon@heraldcorp.com)

CJ CheilJedang’s earnings in the fourth quarter last year have improved, said Mirae Asset Daewoo on Jan. 11, raising the target price to 480,000 won (US$448.68) from 450,000 won.